Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
ISORDIL
Generic name / active ingredient
isosorbide dinitrate immediate-release tablets
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Route documented in the linked source label
Record reviewed
2026-08-31

Copy from the pack in hand

Source-linked reading points

  • Check route and release design first: this page covers immediate-release oral tablets, not sublingual or extended-release products. Do not convert, alternate or substitute by milligrams with IMDUR, MONOKET, NITROSTAT or historical ISORDIL sublingual/extended-release products.
  • PDE-5 inhibitors such as sildenafil, tadalafil or vardenafil, and the soluble guanylate cyclase stimulator riociguat, are contraindication-review scenarios with ISORDIL. Do not invent a few-hour separation to bypass them.
  • Dizziness, postural hypotension and syncope may occur. Co-listing antihypertensives, other vasodilators, diuretics or alcohol requires priority review. Unsteadiness on standing, a fall or fainting in an older person needs timely assessment.
  • The labelled 5 mg and 40 mg tablets are deeply scored, but the score is an appearance-identity field and does not permit self-splitting from a website. Check the exact product label and prescriber instructions.

Reviewed presentation examples — compare every field

  • Isosorbide dinitrate 5 mg per tablet; current Orange Book prescription RLDNDA 012093 / Product 007 / NDC 0187-0152-01
  • Isosorbide dinitrate 10 mg per tablet; historical RLD currently DISCNNDA 012093 / Product 002
  • Isosorbide dinitrate 20 mg per tablet; historical RLD currently DISCNNDA 012093 / Product 006
  • Isosorbide dinitrate 30 mg per tablet; historical RLD currently DISCNNDA 012093 / Product 005
  • Isosorbide dinitrate 40 mg per tablet; current Orange Book prescription RLD and also RSNDA 012093 / Product 001 / NDC 0187-0192-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-31
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image